Kepos Capital LP Pet Vivo Holdings, Inc. Transaction History

Kepos Capital LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.3 - $2.63 $305,500 - $618,050	-235,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.4 - $5.01 $216,000 - $450,900	-90,000 Reduced 27.69%	235,000 $886,000
Q3 2021 Nov 12, 2021	BUY	$2.62 - $9.25 $851,500 - $3.01 Million	325,000 New	325,000 $878,000

Ticker PETV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 10,072,000
Market Cap $4.73M
Description
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint affliction...

Get notified when there are updates to the investment portfolio of Kepos Capital LP, based on Form 13F filings with the SEC.

Stay updated on Kepos Capital LP with notifications on news.